1-804-709-0144
ichip-hi-edit

iCHIP® Platform

ImmunArray’s iCHIP® technology mines the information stored in the immune system repertoires in order to shed light on an individual’s specific immune profile.

Learn More

iCHIP intensity

SLE-key®

SLE-key® is a molecular diagnostic test developed by ImmunArray to support a physician’s ability to rule-out a diagnosis of Systemic Lupus Erythematosus (SLE).

Learn More

TBI Program

Immunarray® is developing a series of assays and multiplex tests to assist in the diagnosis and prognosis of Brain Injury, in both acute (TBI) and chronic phases.

Learn More

See Us At

THE 7TH ANNUAL TRAUMATIC BRAIN INJURY CONFERENCE

May 24 – May 25th, 2017, Washington, DC USA

Title: Astroglial injury-defined biomarkers in diagnostic monitoring after mild traumatic brain injury reveals the potential for Aldolase C as new candidate blood biomarker

Authors: Timothy E.

Read More
fan

Recent News & Events

Quanterix and ImmunArray Teaming Up to Address Neurodegenerative Disease

Quanterix gains access to ImmunArray brain injury biomarker portfolio and ImmunArray gains access to Quanterix state of the art digital biomarker technology

Read More
our-story-crop

Talk to Us

Welcome!

We are a clinically driven company guided by leadership physician input at each stage of our development. We welcome questions and open discussions, and look forward to continuing to work with our collaborators and partners around the globe.

Read More